Correlation Between HCW Biologics and Regencell Bioscience

Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Regencell Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Regencell Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HCW Biologics and Regencell Bioscience Holdings, you can compare the effects of market volatilities on HCW Biologics and Regencell Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Regencell Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Regencell Bioscience.

Diversification Opportunities for HCW Biologics and Regencell Bioscience

-0.83

Correlation Coefficient

HCW Biologics  Regencell Bioscience

Pay attention - limited upside

The 3 months correlation between HCW and Regencell is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Regencell Bioscience Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regencell Bioscience and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Regencell Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regencell Bioscience has no effect on the direction of HCW Biologics i.e., HCW Biologics and Regencell Bioscience go up and down completely randomly.

Pair Corralation between HCW Biologics and Regencell Bioscience

Given the investment horizon of 90 days HCW Biologics is expected to generate 0.82 times more return on investment than Regencell Bioscience. However, HCW Biologics is 1.22 times less risky than Regencell Bioscience. It trades about 0.0 of its potential returns per unit of risk. Regencell Bioscience Holdings is currently generating about -0.02 per unit of risk. If you would invest  221.00  in HCW Biologics on February 8, 2024 and sell it today you would lose (93.00) from holding HCW Biologics or give up 42.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	99.8%
Values	Daily Returns

HCW Biologics  vs.  Regencell Bioscience Holdings

HCW Biologics

Risk-Adjusted Performance

5 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Regencell Bioscience

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Regencell Bioscience Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Regencell Bioscience is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with HCW Biologics and Regencell Bioscience

The main advantage of trading using opposite HCW Biologics and Regencell Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Regencell Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regencell Bioscience will offset losses from the drop in Regencell Bioscience's long position.

The idea behind HCW Biologics and Regencell Bioscience Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.